Pharmaceuticals have taken advantage of older glaucoma patients long enough, knowing that the bottle does not last the whole month and making taxpayers spend extra dollars in a new bottle every month.
Also, it is to be reminded that this disease affects the elderly most, an age group which commonly misses the eye drop into the eye, wasting doses.



